{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_20192", "batch_size": 200, "batch_pos": 22, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment reports factual numbers using neutral language.", "method": "llm_batch", "batch_id": "batch_2_14796", "batch_size": 200, "batch_pos": 190, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "'secures' and 'includes' are not moderate verbs on the list.", "method": "llm_batch", "batch_id": "batch_3_4624", "batch_size": 200, "batch_pos": 152, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"hop_idx": 4, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_4_8516", "batch_size": 200, "batch_pos": 148, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment is a statement, not a question.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_4_8516_r1", "batch_size": 200, "batch_pos": 148, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "Reports facts neutrally; lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17400", "batch_size": 200, "batch_pos": 147, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "The segment reports securing 'up to 665,000 doses' and an option for 'a further 40 million' but does not use a minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_2912", "batch_size": 200, "batch_pos": 112, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment describes actions taken/scale (secures doses) but does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_18508", "batch_size": 200, "batch_pos": 92, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes 'The deal secures up to 665,000 doses... and includes an option for a further 40 million vaccines' which is a preparedness measure without calming keywords.", "method": "llm_batch", "batch_id": "batch_8_15292", "batch_size": 200, "batch_pos": 166, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
